High-Cutoff Hemodialysis in Myeloma Cast Nephropathy

Affiliations

¹ Division of of Kidney Diseases and Hypertension, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, New York.
² Division of Hematology and Medical Oncology, Multiple Myeloma Center, Weill Cornell Medical Center, New York Presbyterian Hospital, New York City, New York.

Editorial

Kenar D Jhaveri et al. JAMA. 2017.

. 2017 Dec 5;318(21):2085-2086.

doi: 10.1001/jama.2017.18710.

¹ Division of of Kidney Diseases and Hypertension, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, New York.
² Division of Hematology and Medical Oncology, Multiple Myeloma Center, Weill Cornell Medical Center, New York Presbyterian Hospital, New York City, New York.

No abstract available

Comment on

Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP; MYRE Study Group. Bridoux F, et al. JAMA. 2017 Dec 5;318(21):2099-2110. doi: 10.1001/jama.2017.17924. JAMA. 2017. PMID: 29209721 Free PMC article. Clinical Trial.